Kathryn L Rice
- Role of tiotropium in the treatment of COPDKathryn L Rice
University of Minnesota, Minneapolis, MN, USA
Int J Chron Obstruct Pulmon Dis 2:95-105. 2007..Medico economic analyses suggest that treatment with tiotropium may also be cost-effective, primarily by reducing costs associated with hospitalizations...
- Responses to tiotropium in African-American and Caucasian patients with chronic obstructive pulmonary diseaseKathryn L Rice
Veterans Affairs Medical Center, Minneapolis, Minnesota 55417, USA
Transl Res 152:88-94. 2008..African Americans used fewer respiratory medications than Caucasians in this study. We conclude that tiotropium reduces COPD exacerbations and associated health-care use to a similar extent in African Americans compared with Caucasians...
- Disease management program for chronic obstructive pulmonary disease: a randomized controlled trialKathryn L Rice
Pulmonary Section, Department of Medicine, VA Medical Center, Minneapolis, Minnesota 55417, USA
Am J Respir Crit Care Med 182:890-6. 2010..Objectives: To determine whether a simplified disease management program reduces hospital admissions and emergency department (ED) visits due to COPD...
- Exhaled nitric oxide, systemic inflammation, and the spirometric response to inhaled fluticasone propionate in severe chronic obstructive pulmonary disease: a prospective studyKen M Kunisaki
Division of Pulmonary, Allergy, Critical Care and Sleep, University of Minnesota, USA
Ther Adv Respir Dis 2:55-64. 2008..We evaluated the ability of exhaled nitric oxide (FENO) and serum inflammatory markers (C-reactive protein [CRP], interleukin-6 [IL-6], and interleukin-8 [IL-8]) to independently predict spirometric responses to ICS in patients with COPD...
- Management of acute exacerbations of chronic obstructive pulmonary disease in the elderly : an appraisal of published evidenceKen M Kunisaki
University of Minnesota, Minneapolis, Minnesota, USA
Drugs Aging 24:303-24. 2007..Mucolytic agents, pulmonary rehabilitation, and case management programmes may also reduce exacerbation risk, but the current evidence supporting these interventions is weaker...
- Economic evaluation of a disease management program for chronic obstructive pulmonary diseaseNaresh A Dewan
Pulmonary Section, Department of Medicine, VA Medical Center, Omaha, Nebraska 68105, USA
COPD 8:153-9. 2011..The objectives of this study were to determine the cost of implementing the DM program and its impact on healthcare resource utilization costs compared to UC in high-risk COPD patients...
- Symptom-driven lorazepam protocol for treatment of severe alcohol withdrawal delirium in the intensive care unitDouglas D DeCarolis
Department of Pharmacy, Minneapolis Veterans Affairs Medical Center, Minneapolis, Minnesota 55417, USA
Pharmacotherapy 27:510-8. 2007..To compare outcomes of treating alcohol withdrawal delirium (AWD) with a symptom-driven benzodiazepine protocol versus nonprotocol benzodiazepine infusions in the intensive care unit (ICU)...
- Efficacy trial of live, cold-adapted and inactivated influenza virus vaccines in older adults with chronic obstructive pulmonary disease: a VA cooperative studyGeoffrey J Gorse
Department of Veterans Affairs, Medical Center, Saint Louis University, St Louis, MO, USA
Vaccine 21:2133-44. 2003..17, 0.53), and -0.05 for type B virus (95% CL: -1.13, 0.48). However, there was a possible advantage for TC over TP in reducing respiratory consequences of an influenza season measured by pulmonary function and symptoms at end of study...